{"id":2407,"date":"2025-10-15T15:15:23","date_gmt":"2025-10-15T22:15:23","guid":{"rendered":"https:\/\/puny-toaster.flywheelstaging.com\/?p=2407"},"modified":"2026-09-19T20:20:58","modified_gmt":"2026-09-20T03:20:58","slug":"avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda","status":"publish","type":"post","link":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/","title":{"rendered":"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA"},"content":{"rendered":"<p><strong>Key Takeaways<\/strong><\/p>\n<ul>\n<li>VisiPlate&#8217;s IDE approval allows clinical studies in the US, focusing on safety and effectiveness data collection for the novel glaucoma treatment device.<\/li>\n<li>The device&#8217;s unique metamaterial and multichannel design aim to reduce IOP and minimize blockage risks, offering potential advantages over current surgical treatments.<\/li>\n<li>VITA trial results demonstrated a 40.4% mean IOP reduction and decreased medication use, with a significant portion of patients achieving substantial IOP control.<\/li>\n<li>The IDE approval represents a significant milestone for Avisi Technologies, enabling further investigation of VisiPlate&#8217;s potential benefits for glaucoma patients in the US.<\/li>\n<\/ul>\n<p>Avisi Technologies\u2019 investigational device exemption (IDE) submission for its glaucoma treatment device VisiPlate has been approved by the US Food and Drug Administration (FDA).1<\/p>\n<p>As defined by the FDA, an IDE allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data. Additionally, an approved IDE permits a device to be \u201cshipped lawfully for the purpose of conducting investigations of the device without complying with other requirements of the Food, Drug, and Cosmetic Act (FD&amp;C Act) that would apply to devices in commercial distribution.\u201d2<\/p>\n<p><a href=\"https:\/\/www.ophthalmologytimes.com\/view\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways VisiPlate&#8217;s IDE approval allows clinical studies in the US, focusing on safety and effecti [&hellip;]<\/p>\n","protected":false},"author":486,"featured_media":1627,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[150],"tags":[],"class_list":["post-2407","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA - Avisi Technologies Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA - Avisi Technologies Inc.\" \/>\n<meta property=\"og:description\" content=\"Key Takeaways VisiPlate&#8217;s IDE approval allows clinical studies in the US, focusing on safety and effecti [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"Avisi Technologies Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T22:15:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-20T03:20:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/avisitech.com\/wp-content\/uploads\/2025\/10\/Ophthalmology-Times.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1257\" \/>\n\t<meta property=\"og:image:height\" content=\"839\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ivankornienko\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ivankornienko\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/\"},\"author\":{\"name\":\"ivankornienko\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/person\\\/8912f5bbc34efc0fee96277c64d105a5\"},\"headline\":\"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA\",\"datePublished\":\"2025-10-15T22:15:23+00:00\",\"dateModified\":\"2026-09-20T03:20:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/\"},\"wordCount\":200,\"publisher\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Ophthalmology-Times.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/\",\"url\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/\",\"name\":\"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA - Avisi Technologies Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Ophthalmology-Times.png\",\"datePublished\":\"2025-10-15T22:15:23+00:00\",\"dateModified\":\"2026-09-20T03:20:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#primaryimage\",\"url\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Ophthalmology-Times.png\",\"contentUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Ophthalmology-Times.png\",\"width\":1257,\"height\":839,\"caption\":\"Ophthalmology Times Cutting-Edge Advancements Avisi Technologies FDA, IDE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#website\",\"url\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/\",\"name\":\"Avisi Technologies Inc.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#organization\",\"name\":\"Avisi Technologies Inc.\",\"url\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Avisi-Technologies-Logo-SVG-Final-1.svg\",\"contentUrl\":\"https:\\\/\\\/avisitech.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Avisi-Technologies-Logo-SVG-Final-1.svg\",\"width\":124,\"height\":43,\"caption\":\"Avisi Technologies Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/avisitech.com\\\/ja\\\/#\\\/schema\\\/person\\\/8912f5bbc34efc0fee96277c64d105a5\",\"name\":\"ivankornienko\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g\",\"caption\":\"ivankornienko\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA - Avisi Technologies Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/","og_locale":"ja_JP","og_type":"article","og_title":"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA - Avisi Technologies Inc.","og_description":"Key Takeaways VisiPlate&#8217;s IDE approval allows clinical studies in the US, focusing on safety and effecti [&hellip;]","og_url":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/","og_site_name":"Avisi Technologies Inc.","article_published_time":"2025-10-15T22:15:23+00:00","article_modified_time":"2026-09-20T03:20:58+00:00","og_image":[{"width":1257,"height":839,"url":"https:\/\/avisitech.com\/wp-content\/uploads\/2025\/10\/Ophthalmology-Times.png","type":"image\/png"}],"author":"ivankornienko","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ivankornienko","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#article","isPartOf":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/"},"author":{"name":"ivankornienko","@id":"https:\/\/avisitech.com\/ja\/#\/schema\/person\/8912f5bbc34efc0fee96277c64d105a5"},"headline":"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA","datePublished":"2025-10-15T22:15:23+00:00","dateModified":"2026-09-20T03:20:58+00:00","mainEntityOfPage":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/"},"wordCount":200,"publisher":{"@id":"https:\/\/avisitech.com\/ja\/#organization"},"image":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2025\/10\/Ophthalmology-Times.png","articleSection":["News"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/","url":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/","name":"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA - Avisi Technologies Inc.","isPartOf":{"@id":"https:\/\/avisitech.com\/ja\/#website"},"primaryImageOfPage":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#primaryimage"},"image":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2025\/10\/Ophthalmology-Times.png","datePublished":"2025-10-15T22:15:23+00:00","dateModified":"2026-09-20T03:20:58+00:00","breadcrumb":{"@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#primaryimage","url":"https:\/\/avisitech.com\/wp-content\/uploads\/2025\/10\/Ophthalmology-Times.png","contentUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2025\/10\/Ophthalmology-Times.png","width":1257,"height":839,"caption":"Ophthalmology Times Cutting-Edge Advancements Avisi Technologies FDA, IDE"},{"@type":"BreadcrumbList","@id":"https:\/\/avisitech.com\/ja\/avisi-technologies-investigational-device-exemption-for-visiplate-approved-by-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/avisitech.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Avisi Technologies\u2019 investigational device exemption for VisiPlate approved by FDA"}]},{"@type":"WebSite","@id":"https:\/\/avisitech.com\/ja\/#website","url":"https:\/\/avisitech.com\/ja\/","name":"Avisi Technologies Inc.","description":"","publisher":{"@id":"https:\/\/avisitech.com\/ja\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/avisitech.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/avisitech.com\/ja\/#organization","name":"Avisi Technologies Inc.","url":"https:\/\/avisitech.com\/ja\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/avisitech.com\/ja\/#\/schema\/logo\/image\/","url":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/Avisi-Technologies-Logo-SVG-Final-1.svg","contentUrl":"https:\/\/avisitech.com\/wp-content\/uploads\/2024\/01\/Avisi-Technologies-Logo-SVG-Final-1.svg","width":124,"height":43,"caption":"Avisi Technologies Inc."},"image":{"@id":"https:\/\/avisitech.com\/ja\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/avisitech.com\/ja\/#\/schema\/person\/8912f5bbc34efc0fee96277c64d105a5","name":"ivankornienko","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/302018db4e1d52c0124450ceca39d595309c13b7907918bd1357932b410ecc81?s=96&d=mm&r=g","caption":"ivankornienko"}}]}},"_links":{"self":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts\/2407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/users\/486"}],"replies":[{"embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/comments?post=2407"}],"version-history":[{"count":1,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts\/2407\/revisions"}],"predecessor-version":[{"id":2412,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/posts\/2407\/revisions\/2412"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/media\/1627"}],"wp:attachment":[{"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/media?parent=2407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/categories?post=2407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avisitech.com\/ja\/wp-json\/wp\/v2\/tags?post=2407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}